SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,490.00    40.00 (0.90%)
Bid:
4,400.00
Ask:
4,580.00
Spread: 180.00 (4.091%)
Market Cap: £299.07m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Further re Acquisition

18 Jun 2009 12:54

RNS Number : 1287U
Judges Scientific PLC
18 June 2009
 

18 June 2009

JUDGES SCIENTIFIC plc

("Judges Scientific" or the "Company")

NEW BANK FACILITIES

FOLLOWING THE RECENTLY-ANNOUNCED ACQUISITION OF

QUORUM TECHNOLOGIES LIMITED

On 10 June 2009Judges Scientific plcthe parent company of a group that specialises in the design, manufacture and sale of scientific instruments, announced that it had completed the acquisition of the entire issued share capital of Quorum Technologies Limited ("Quorum" or the "Acquisition") for a total consideration of up to £1.5 million. The announcement stated that the Acquisition had been financed out of surplus funds, though the Bank of Scotland had agreed (subject to the finalisation of documentation) to make available a £4 million term loan Othis amount, £3 million would be drawn down to refinance both the acquisition and the Company's existing borrowing, of which approximately £1.7 million remained outstanding. The additional £1 million would be conditionally available to be drawn down in the event of further M&A activity. In addition, a £500,000 overdraft facility would continue to be available to the Company.

The Company now announces that the documentation in relation to the proposed Bank of Scotland facility has been completed as anticipated and that the £3 million term loan referred to above was drawn down on 18 June 2009.

Alex Hambro, Chairman of Judges Scientific, commented: "I am delighted that we have successfully completed the refinancing of our activities and of the Quorum acquisition. This leaves us with a prudent level of financial headroom to support our expanded range of activities and to pursue our strategy of enhancing earnings through the acquisition of niche businesses in our sector."

Enquiries:

David Cicurel, CEO, Judges Scientific: Tel: 01342 323 600

 

Pascal Keane, Shore Capital:     Tel: 020 7408 4090

Melvyn Marckus, Cardew Group:  Tel: 07775 896 491

Web sites:

Judges Scientific: www.judges.uk.com

Quorum: www.quorumtech.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FURCKFKPDBKDBAD
Date   Source Headline
6th Apr 20232:50 pmRNSDirector/PDMR Shareholding
4th Apr 202312:21 pmRNSTotal Voting Rights
3rd Apr 20237:01 amRNSAcquisition of Henniker Scientific Limited
3rd Apr 20237:00 amRNSAppointment of Joint Broker
31st Mar 20238:54 amRNSGrant of Options
22nd Mar 20237:00 amRNSFinal Results
8th Mar 20232:39 pmRNSTotal Voting Rights
8th Mar 20237:00 amRNSDirector/PDMR Shareholding
13th Feb 20238:48 amRNSDirector/PDMR Shareholding
2nd Feb 20239:17 amRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSExecutive Director and Board Appointment
1st Feb 20237:00 amRNSTotal Voting Rights
23rd Jan 202310:27 amRNSGrant of Options
19th Jan 20237:00 amRNSFull Year Trading Statement and Notice of Results
9th Jan 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20231:03 pmRNSTotal Voting Rights
21st Dec 202210:51 amRNSBlock listing Interim Review
20th Dec 202211:53 amRNSDirector/PDMR Shareholding
12th Dec 20228:52 amRNSHolding(s) in Company
6th Dec 20222:34 pmRNSDirector/PDMR Shareholding
1st Dec 202210:01 amRNSTotal Voting Rights
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20228:54 amRNSDirector/PDMR Shareholding
7th Nov 20225:14 pmRNSDirector/PDMR Shareholding
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
4th Oct 20223:55 pmRNSDirector/PDMR Shareholding
3rd Oct 202210:01 amRNSTotal Voting Rights
23rd Sep 20223:44 pmRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSInterim Results
6th Sep 20222:51 pmRNSDirector/PDMR Shareholding
2nd Sep 20223:16 pmRNSTotal Voting Rights
9th Aug 20229:20 amRNSDirector/PDMR Shareholding
1st Aug 202211:07 amRNSTotal Voting Rights
27th Jul 20224:08 pmRNSDirector/PDMR Shareholding
25th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
8th Jul 20228:12 amRNSDirector/PDMR Shareholding
1st Jul 20225:34 pmRNSTotal Voting Rights
29th Jun 202211:13 amRNSDirector/PDMR Shareholding
27th Jun 20227:00 amRNSAcquisition of minority shareholding in Bordeaux
21st Jun 20227:00 amRNSDirector/PDMR Shareholding
10th Jun 202211:43 amRNSBlocklisting Return
9th Jun 202212:11 pmRNSDirector/PDMR Shareholding
9th Jun 20227:36 amRNSIssue of Shares – Replacement
8th Jun 20223:52 pmRNSIssue of Ordinary Shares
6th Jun 20223:00 pmRNSPurchase of Ordinary Shares
1st Jun 202212:48 pmRNSTotal Voting Rights
27th May 20221:08 pmRNSAppointment of auditor
24th May 20222:12 pmRNSResult of AGM
23rd May 202211:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.